CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 8,411 enrolled
Drug / intervention
Ergoferondrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04413929
NCT04413929N/ACompleted
CompareCT.gov

International Observational Non-Interventional Retrospective Program for Studying the Efficiency and Safety of Ergoferon in Patients With Influenza and Acute Respiratory Viral Infection (ARVI).

Materia Medica Holding·observational·Posted Jun 4, 2020·Updated Apr 2, 2021

In Brief

An observational study evaluating Ergoferon for Viral Respiratory Infection. Completed, enrolled 8,411 participants.

Detailed Summary

The observational study to get the additional data of the safety and effectiveness of Ergoferon in the treatment of influenza/ARVI in adult and pediatric outpatients.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsViral Respiratory Infection
Countries--
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedJun 4, 2020
Enrollment StartOct 1, 2016
Primary CompletionApr 1, 2017
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 6.1 years ago

Interventions

Ergoferondrug

Oral administration